Pediatric Acute Asthma Exacerbation
Child with acute wheeze/dyspnea
All Pathways
PediatricsEmergency
Pediatric Acute Asthma Exacerbation (GINA 2025)
Pediatric Acute Asthma Exacerbation (GINA 2025): Pediatric Acute Asthma Exacerbation → Assess Severity → Mild-Moderate Treatment → Response After 1 Hour...
Pathway Overview
9 steps
Algorithm Steps
9 total
01Start 02Action Assess Severity
Clinical assessment
- MILD-MODERATE:
- • Talks in phrases, prefers sitting
- • Not agitated, SpO2 ≥92%
- • HR increased but not severe
- SEVERE:
- • Talks in words only, sits hunched forward
- • Agitated, SpO2 <92%
- • Accessory muscle use, RR >30
- LIFE-THREATENING:
- • Silent chest, cyanosis, exhaustion
- • Altered consciousness, SpO2 <90%
03Action Mild-Moderate Treatment
Initial bronchodilator therapy
- SABA: Salbutamol (albuterol)
- • pMDI + spacer: 4-6 puffs
- • OR nebulizer: 2.5 mg (5 mg if >40 kg)
- • Repeat every 20 min x3 in first hour
- ORAL CORTICOSTEROID:
- • Prednisolone 1-2 mg/kg (max 40 mg)
- • Give within first hour
- Maintain SpO2 ≥94% (≥92% for age ≥12)
04Decision Response After 1 Hour?
Reassess after initial treatment
05Outcome Good Response
Improving - consider discharge
- Observe 1-2 hours
- SpO2 ≥94% on room air
- PEF/FEV1 ≥60-80% predicted
- DISCHARGE WITH:
- • Continue SABA q3-4h prn
- • Oral prednisolone 3-5 days
- • Review ICS adherence
- • Follow-up within 1-2 weeks
06Action Poor Response
Escalate therapy
- Continue SABA q1h or continuous neb
- Continue ipratropium q4-6h
- ADD MAGNESIUM SULFATE IV:
- • 25-50 mg/kg (max 2 g)
- • Infuse over 20-30 minutes
- • Single dose (may repeat once)
- Consider high-flow nasal cannula
- ICU consultation if not improving
07Outcome Admit to Hospital
Criteria for admission
- SpO2 <92% on room air
- Requiring ongoing O2/frequent SABA
- Poor response to initial treatment
- Previous severe exacerbations
- Unable to take oral steroids
- Inadequate home support
08Warning Life-Threatening/ICU
Critical care required
- IMMEDIATE:
- • Nebulized SABA continuous
- • Ipratropium + magnesium sulfate IV
- • IV corticosteroids
- CONSIDER:
- • IV salbutamol 5-15 mcg/kg loading, then 1-5 mcg/kg/min
- • Aminophylline (limited evidence)
- • BiPAP or intubation if failing
- • Ketamine for intubation
- AVOID: Aggressive sedation, high PEEP
09Action Severe Exacerbation
Intensive initial treatment
- SABA: Salbutamol continuous/q20min
- • 2.5-5 mg neb back-to-back x3
- ADD IPRATROPIUM:
- • 250-500 mcg neb with SABA
- • For first hour (3 doses)
- OXYGEN: Target SpO2 94-98%
- SYSTEMIC STEROIDS:
- • Prednisolone 1-2 mg/kg PO (max 40 mg)
- • OR Methylprednisolone 1-2 mg/kg IV
- Path rejoins step 04Shared downstream outcome
- Path rejoins step 08Shared downstream outcome
Guideline Source
GINA 2025 - Global Strategy for Asthma Management
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Different management for children ≤5 years
- Does not address maintenance therapy
Applicable Regions
USEU
Version 1Next review: 2027-01-11
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Pediatric Acute Asthma Exacerbation (GINA 2025)?
The Pediatric Acute Asthma Exacerbation (GINA 2025) is a emergency clinical algorithm for Pediatrics. It provides a structured decision tree to guide clinical decision-making, based on GINA 2025 - Global Strategy for Asthma Management.
What guideline is the Pediatric Acute Asthma Exacerbation (GINA 2025) based on?
This algorithm is based on GINA 2025 - Global Strategy for Asthma Management.
What are the limitations of the Pediatric Acute Asthma Exacerbation (GINA 2025)?
Known limitations include: Different management for children ≤5 years; Does not address maintenance therapy. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Pediatric Acute Asthma Exacerbation (GINA 2025) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free